Discontinued — last reported Q4 '22
Investing
CapEx
Incyte CapEx decreased by 23.5% to $21.27M in Q4 2022 compared to the prior quarter. Year-over-year, this metric declined by 38.3%, from $34.46M to $21.27M.
Analysis
StatementCash Flow Statement
SectionInvesting
First reportedQ1 2013
Last reportedQ4 2022Feb 7, 2023
Metric ID:
capital_expendituresHistorical Data
7 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | |
|---|---|---|---|---|---|---|---|
| Value | $66.31M | $32.15M | $34.46M | $17.01M | $11.74M | $27.81M | $21.27M |
| QoQ Change | — | -51.5% | +7.2% | -50.7% | -30.9% | +136.8% | -23.5% |
| YoY Change | — | — | — | — | -82.3% | -13.5% | -38.3% |
Range$11.74M – $66.31M
CAGR-53.1%
Avg YoY Growth-44.7%
Median YoY Growth-38.3%
CapEx at Other Companies
Frequently Asked Questions
- What is Incyte's capex?
- Incyte (INCY) reported capex of $21.27M in Q4 2022.
- How has Incyte's capex changed year-over-year?
- Incyte's capex decreased by 38.3% year-over-year, from $34.46M to $21.27M.